MARGARET BYRAM: Open Payments
NPI 1396933065 · SURF CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 23 payments from 10 companies in 2025. Trend: 2023 $136 · 2024 $48 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $96 |
| Astellas Pharma US Inc | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Novo Nordisk Inc | 3 | $54 |
| Amgen Inc. | 2 | $31 |
| Exeltis, USA Inc. | 1 | $24 |
| Bausch Health US, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
Products named: HETLIOZ, Veozah, BREZTRI, Wegovy, SLYND, Rybelsus, APLENZIN, OTEZLA.
Industry payments across NC — which companies pay providers there.
